149 related articles for article (PubMed ID: 38754633)
41. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
42. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
[TBL] [Abstract][Full Text] [Related]
43. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
Bai B; Myklebust JH; Wälchli S
Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
[TBL] [Abstract][Full Text] [Related]
44. TAxI-peptide targeted Cas12a ribonuclease protein nanoformulations increase genome editing in hippocampal neurons.
Sellers DL; Lee K; Murthy N; Pun SH
J Control Release; 2023 Feb; 354():188-195. PubMed ID: 36596342
[TBL] [Abstract][Full Text] [Related]
45. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein.
Dhokane D; Bhadra B; Dasgupta S
Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412
[TBL] [Abstract][Full Text] [Related]
46. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
47. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.
Chen G; Abdeen AA; Wang Y; Shahi PK; Robertson S; Xie R; Suzuki M; Pattnaik BR; Saha K; Gong S
Nat Nanotechnol; 2019 Oct; 14(10):974-980. PubMed ID: 31501532
[TBL] [Abstract][Full Text] [Related]
48. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
49. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
50. DNA-Free Genome Editing via Ribonucleoprotein (RNP) Delivery of CRISPR/Cas in Lettuce.
Park J; Choi S; Park S; Yoon J; Park AY; Choe S
Methods Mol Biol; 2019; 1917():337-354. PubMed ID: 30610648
[TBL] [Abstract][Full Text] [Related]
51. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
52. Genome Editing in a Wide Area of the Brain Using Dendrimer-Based Ternary Polyplexes of Cas9 Ribonucleoprotein.
Taharabaru T; Yokoyama R; Higashi T; Mohammed AFA; Inoue M; Maeda Y; Niidome T; Onodera R; Motoyama K
ACS Appl Mater Interfaces; 2020 May; 12(19):21386-21397. PubMed ID: 32315156
[TBL] [Abstract][Full Text] [Related]
53. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.
Martin RM; Ikeda K; Cromer MK; Uchida N; Nishimura T; Romano R; Tong AJ; Lemgart VT; Camarena J; Pavel-Dinu M; Sindhu C; Wiebking V; Vaidyanathan S; Dever DP; Bak RO; Laustsen A; Lesch BJ; Jakobsen MR; Sebastiano V; Nakauchi H; Porteus MH
Cell Stem Cell; 2019 May; 24(5):821-828.e5. PubMed ID: 31051134
[TBL] [Abstract][Full Text] [Related]
54. CRISPR/Cas9-mediated gene replacement in the basidiomycetous yeast Pseudozyma antarctica.
Kunitake E; Tanaka T; Ueda H; Endo A; Yarimizu T; Katoh E; Kitamoto H
Fungal Genet Biol; 2019 Sep; 130():82-90. PubMed ID: 31026589
[TBL] [Abstract][Full Text] [Related]
55. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes.
Staahl BT; Benekareddy M; Coulon-Bainier C; Banfal AA; Floor SN; Sabo JK; Urnes C; Munares GA; Ghosh A; Doudna JA
Nat Biotechnol; 2017 May; 35(5):431-434. PubMed ID: 28191903
[TBL] [Abstract][Full Text] [Related]
56. Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes.
Meccariello A; Monti SM; Romanelli A; Colonna R; Primo P; Inghilterra MG; Del Corsano G; Ramaglia A; Iazzetti G; Chiarore A; Patti F; Heinze SD; Salvemini M; Lindsay H; Chiavacci E; Burger A; Robinson MD; Mosimann C; Bopp D; Saccone G
Sci Rep; 2017 Aug; 7(1):10061. PubMed ID: 28855635
[TBL] [Abstract][Full Text] [Related]
57. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
58. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
[TBL] [Abstract][Full Text] [Related]
59. In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction.
Park H; Kim D; Cho B; Byun J; Kim YS; Ahn Y; Hur J; Oh YK; Kim J
Biomaterials; 2022 Feb; 281():121327. PubMed ID: 34952262
[TBL] [Abstract][Full Text] [Related]
60. Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon Skipping.
Watanabe K; Gee P; Hotta A
Methods Mol Biol; 2023; 2587():427-453. PubMed ID: 36401042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]